DIN 02508095 — TRI-CIRA 28 0.215 MG; 0.25 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG
TRI-CIRA 28 is a tablet of Ethinyl Estradiol / Norgestimate marketed by APOTEX INC. The full Ethinyl Estradiol / Norgestimate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02508095
- Brand name
- TRI-CIRA 28
- Active ingredient
- Ethinyl Estradiol / Norgestimate
- Strength
- 0.215 MG; 0.25 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Estrogen-progestin combination (combined oral contraceptive, triphasic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ethinyl Estradiol / Norgestimate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02508087 | TRI-CIRA 21 | 0.25 MG; 0.035 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.215 MG | TABLET | APOTEX INC | MARKETED |
| 02401967 | TRI-CIRA LO 21 | 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG | TABLET | APOTEX INC | MARKETED |
| 02401975 | TRI-CIRA LO 28 | 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG | TABLET | APOTEX INC | MARKETED |
| 02486296 | TRI-JORDYNA 21 | 0.035 MG; 0.035 MG; 0.035 MG; 0.18 MG; 0.215 MG; 0.25 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02486318 | TRI-JORDYNA 28 | 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG; 0.25 MG; 0.215 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |